Oncimmune Holdings PLC (ONC)

Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

19.00p

Buy

20.40p

arrow-down-4.80p (-19.59%)

Prices updated at 31 May 2024, 16:27 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Oncimmune Holdings PLC is a cancer detection company engaged in developing and commercializing its proprietary EarlyCDT platform technology. Its product EarlyCDT-Lung is a simple blood test to aid the risk assessment and early detection of lung cancer.
FTSE All-Share
arrow-up0.5%
LSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
24.50
triangle-d
arrow-down
-1.90 (-7.76%)
triangle-d
Today open
22.60
triangle-d
arrow-down
-2.90 (-12.83%)
triangle-d
Today, 16:27:18 BST
19.70
triangle-d
22.60p - 19.24p
31.00p - 13.00p
-
14.61m
-
10,000
147,940
-
71,157.88
1.70
74.14m
GB00BYQ94H38
0.11
-
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.